Photo of Professor David Werring

Professor David Werring

Email:

Location:

  • National Hospital for Neurology and Neurosurgery
  • University College Hospital

GMC/GDC number:

3663381

Professional background

Professor Werring trained in medicine at Guy’s Hospital Medical School and undertook neurology and medical training in London including King’s College Hospital, the Maudsley Hospital, St Thomas' Hospital, and The National Hospital, Queen Square.

He was appointed consultant neurologist at The National Hospital, Queen Square, University College Hospital (UCH) and Watford General Hospital in 2005. In 2015 David was appointed as Professor of Clinical Neurology at the Stroke Research Centre, UCL Queen Square Institue of Neurology.

Professor Werring contributes to delivering hyperacute and acute stroke care, and runs a specialist clinical service and research program in intracerebral haemorrhage and cerebral small vessel disease (particularly cerebral amyloid angiopathy), as well as superficial siderosis of the central nervous system. He is Head of the Research Department of Brain Repair and Rehabilitation at the Institute of Neurology, Chair of the Association of British neurologists Stroke Advisory Group, Stroke Specialty Lead for the NIHR North Thames Clinical Research Network, Secretary of the British Association of Stroke Physicians, Expert Advisor to the NICE centre for guidelines, and on the Editorial Boards of the European Journal of Neurology, European Stroke Journal, and Practical Neurology. David is also Chair for the UK Stroke Forum, the largest multidisciplinary event for stroke care professionals in the UK.

Specialties

Research interests

  • Stroke and transient ischaemic attack
  • Cerebral small vessel disease, particularly neuroimaging
  • Intracerebral haemorrhage
  • Cerebral amyloid angiopathy
  • Atrial fibrillation and anticoagulation
  • Superficial siderosis of the central nervous system

Publications

Professor Werring has published over 300 papers and contributed to several books. He is an editor of the forthcoming Queen Square textbook of Neurology. A more comprehensive list of publications can be found at https://pubmed.ncbi.nlm.nih.gov/?term=werring&sort=date.amd also at https://scholar.google.co.uk/citations?hl=en&user=2MYHXBMAAAAJ

Selected publications:

1: Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, Shah S, Simister RJ, Turner D, Chandratheva A, Werring DJ. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):889-891. doi:10.1136/jnnp-2020-323586. Epub 2020 Apr 30. PMID: 32354768; PMCID: PMC7231545.

2: Seiffge DJ, De Marchis GM, Koga M, Paciaroni M, Wilson D, Cappellari M, Macha Md K, Tsivgoulis G, Ambler G, Arihiro S, Bonati LH, Bonetti B, Kallmünzer B, Muir KW, Bovi P, Gensicke H, Inoue M, Schwab S, Yaghi S, Brown MM, Lyrer P, Takagi M, Acciarrese M, Jager HR, Polymeris AA, Toyoda K, Venti M, Traenka C, Yamagami H, Alberti A, Yoshimura S, Caso V, Engelter ST, Werring DJ; RAF, RAF-DOAC, CROMIS-2, SAMURAI, NOACISP, Erlangen, and Verona registry collaborators. Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation. Ann Neurol. 2020 Feb 12;87(5):677–87. doi: 10.1002/ana.25700. Epub ahead of print. PMID: 32052481; PMCID: PMC7383617.

3: Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, Chabriat H, Hennerici M, Wong YK, Mak HKF, Prats-Sánchez L, Martínez-Domeño A, Inamura S, Yoshifuji K, Arsava EM, Horstmann S, Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ N, Abrigo J, Leung T, Chu W, Chappell F, Makin S, Hayden D, Williams DJ, Kooi ME, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Mendyk AM, Delmaire C, Köhler S, van Oostenbrugge R, Zhou Y, Xu C, Hilal S, Gyanwali B, Chen C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, Jung S, Kwa VIH, Engelter ST, Peters N, Smith EE, Yakushiji Y, Orken DN, Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez-Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas J, Werring DJ; Microbleeds International Collaborative Network. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies. Lancet Neurol. 2019 Jul;18(7):653-665. doi: 10.1016/S1474-4422(19)30197-8. Epub 2019 May 23.

4: Seiffge DJ, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M, Schaedelin S, Shakeshaft C, Takagi M, Tsivgoulis G, Bonetti B, Kallmünzer B, Arihiro S, Alberti A, Polymeris AA, Ambler G, Yoshimura S, Venti M, Bonati LH, Muir KW, Yamagami H, Thilemann S, Altavilla R, Peters N, Inoue M, Bobinger T, Agnelli G, Brown MM, Sato S, Acciarresi M, Jager HR, Bovi P, Schwab S, Lyrer P, Caso V, Toyoda K, Werring DJ, Engelter ST, De Marchis GM; CROMIS-2, RAF, RAF-DOAC, SAMURAI, NOACISP LONGTERM, Erlangen and Verona registry collaborators. Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol. 2019 Jun;85(6):823-834. doi: 10.1002/ana.25489. Epub 2019 Apr 30. PMID: 30980560; PMCID: PMC6563449.

5: Banerjee G, Adams ME, Jaunmuktane Z, Alistair Lammie G, Turner B, Wani M,Sawhney IMS, Houlden H, Mead S, Brandner S, Werring DJ. Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura. Ann Neurol. 2019 Feb;85(2):284-290. doi: 10.1002/ana.25407. Epub 2019 Jan 17. PMID: 30597599; PMCID: PMC6492172.

6: Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter ST, Fischer U, Norrving B. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. Lancet Neurol. 2019 Jan;18(1):117-126. doi: 10.1016/S1474-4422(18)30356-9. Epub 2018 Nov 8. PMID: 30415934; PMCID: PMC6524642.

7: Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, Lip GYH, Cohen H, Banerjee G, Houlden H, White MJ, Yousry TA, Harkness K, Flossmann E, Smyth N, Shaw LJ, Warburton E, Muir KW, Jäger HR, Werring DJ; CROMIS-2 collaborators. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018 Jun;17(6):539-547. doi: 10.1016/S1474-4422(18)30145-5. Epub 2018 May 16. Erratum in: Lancet Neurol. 2018 Jul;17(7):578. PMID: 29778365; PMCID: PMC5956310.

8: Banerjee G, Stone SP, Werring DJ. Posterior circulation ischaemic stroke.BMJ. 2018 Apr 19;361:k1185. doi: 10.1136/bmj.k1185. PMID: 29674391.